Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Revenue (2017 - 2026)

Updated

Moderna (MRNA) posted Revenue of $145 million for Q2 2026, up 2.1% from $142 million a year earlier but down 62.7% from the prior quarter.

Analysis

Moderna (MRNA) Revenue (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at Moderna was $2.23 billion, down 27.6% year-over-year; for FY2025, it came in at $1.94 billion, down 39.9% from FY2024.

  • Annual Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • In prior years, Moderna's Revenue was $3.24 billion in FY2024 (-52.7%), $6.85 billion in FY2023 (-64.4%), $19.26 billion in FY2022 (+4.3%) and $18.47 billion in FY2021.
  • Quarterly Revenue has run from a low of $108 million in Q1 2025 to a high of $7.21 billion in Q4 2021 over five years.
  • On a year-over-year basis, Revenue increased in three of the last eight quarters, with growth averaging 5.8%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q1 2026, with growth of 260.2%; the weakest was Q2 2023, with a decline of 92.8%.
  • According to Business Quant data, Revenue for the three prior quarters was $389 million (Q1 2026), $678 million (Q4 2025) and $1.02 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 25.31 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 16.99 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 15.38 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 7.80 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 15.03 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 145.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 145.00 Mn
Mar 31, 2026 389.00 Mn
Dec 31, 2025 678.00 Mn
Sep 30, 2025 1.02 Bn
Jun 30, 2025 142.00 Mn
Mar 31, 2025 108.00 Mn
Dec 31, 2024 966.00 Mn
Sep 30, 2024 1.86 Bn
Jun 30, 2024 241.00 Mn
Mar 31, 2024 167.00 Mn
Dec 31, 2023 2.81 Bn
Sep 30, 2023 1.83 Bn
Jun 30, 2023 344.00 Mn
Mar 31, 2023 1.86 Bn
Dec 31, 2022 5.08 Bn
Sep 30, 2022 3.36 Bn
Jun 30, 2022 4.75 Bn
Mar 31, 2022 6.07 Bn
Dec 31, 2021 7.21 Bn
Sep 30, 2021 4.97 Bn
API Access

Moderna Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY